| Literature DB >> 31809501 |
Veronika Schmidt1,2, Marie-Claire O'Hara1,3, Bernard Ngowi4,5, Karl-Heinz Herbinger6, John Noh7, Patricia Procell Wilkins7, Vivien Richter8, Christian Kositz9, William Matuja10, Andrea Sylvia Winkler1,2.
Abstract
In Africa, urbanization is happening faster than ever before which results in new implications for transmission of infectious diseases. For the zoonotic parasite Taenia solium, a major cause of acquired epilepsy in endemic countries, the prevalence in urban settings is unknown. The present study investigated epidemiological, neurological, and radiological characteristics of T. solium cysticercosis and taeniasis (TSCT) in people with epilepsy (PWE) living in Dar es Salaam, Tanzania, one of the fastest growing cities worldwide. A total of 302 PWE were recruited from six health centers in the Kinondoni district of Dar es Salaam. Serological testing for T. solium cysticercosis-antigen (Ag) and -antibodies (Abs) and for T. solium taeniasis-Abs was performed in all PWE. In addition, clinical and radiological examinations that included cranial computed tomography (CT) were performed. With questionnaires, demographic data from study populations were collected, and factors associated with TSCT were assessed. Follow-up examinations were conducted in PWE with TSCT. T. solium cysticercosis-Ag was detected in three (0.99%; 95% CI: 0-2.11%), -Abs in eight (2.65%; 95% CI: 0.84-4.46%), and taeniasis-Abs in five (1.66%; 95% CI: 0.22-3.09%) of 302 PWE. Six PWE (1.99%; 95% CI: 0.41-3.56%) were diagnosed with neurocysticercosis (NCC). This study demonstrates the presence of TSCT in Dar es Salaam, however, NCC was only associated with a few cases of epilepsy. The small fraction of PWE with cysticercosis- and taeniasis-Abs may suggest that active transmission of T. solium plays only a minor role in Dar es Salaam. A sufficiently powered risk analysis was hampered by the small number of PWE with TSCT; therefore, further studies are required to determine the exact routes of infection and risk behavior of affected individuals.Entities:
Year: 2019 PMID: 31809501 PMCID: PMC6897529 DOI: 10.1371/journal.pntd.0007751
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1Location of recruitment centers with the distribution of urban and peri-urban areas.
Buildings, roads, railways, waterways, and forest data are copyrighted by OpenStreetMap contributors and available from https://www.openstreetmap.org (OpenStreetMap contributors (2016) Planet Dump [Data file from 2016 Aug. 18]). Extract retrieved 2016 Aug. 23 from BBBike, https://download.bbbike.org/osm/). Country, region, district, and ward boundaries are from the GADM database of Global Administrative Areas, v2.8 (November 2015).
Fig 2Workflow of recruitment and examinations of people with epilepsy (PWE).
CC: cysticercosis; LLGP-EITB: lentil lectin purified glycoprotein enzyme-linked immunoelectrotransfer blot; rT24H-IB: rT24H-immunoblot; Ag: antigen; ELISA: enzyme-linked immunosorbent assay; rES33-IB: rES33-immunoblot; CT: computed tomography; TSCT: T. solium cysticercosis and taeniasis; AED: anti-epileptic drugs.
Fig 3Sex and age distribution of the study population.
Socio-demographics and associated factors for T. solium cysticercosis and taeniasis among people with epilepsy.
| Variables | People with epilepsy | ||||||
|---|---|---|---|---|---|---|---|
| seropositive for | seronegative for | ||||||
| Number | Proportions | Proportions | Number | Proportions | Proportions | ||
| Total | 8 | 100 | - | 294 | 100 | - | |
| Sex | 1.00 | ||||||
| Female | 4 | 50.00 | - | 156 | 53.06 | - | |
| Male | 4 | 50.00 | - | 138 | 46.94 | - | |
| Age | 0.24 | ||||||
| 6–19 years | 3 | 37.50 | - | 108 | 36.73 | - | |
| 20–39 years | 3 | 37.50 | - | 144 | 48.98 | - | |
| 40–59 years | 1 | 12.50 | - | 37 | 12.59 | - | |
| 60–85 years | 1 | 12.50 | - | 5 | 1.70 | - | |
| School education | 0.71 | ||||||
| Data known | 7 | 87.50 | 100 | 289 | 98.30 | 100 | |
| None | 0 | 0 | 0 | 24 | 8.16 | 8.30 | |
| ≤7 years | 6 | 75.00 | 85.71 | 242 | 82.31 | 83.74 | |
| 8–11 years | 1 | 12.50 | 14.29 | 23 | 7.82 | 7.96 | |
| Religion | 0.74 | ||||||
| Christian | 5 | 62.50 | - | 145 | 49.32 | - | |
| Muslim | 3 | 37.50 | - | 146 | 49.66 | - | |
| Other | 0 | 0 | - | 3 | 1.02 | - | |
| Occupation | 0.83 | ||||||
| Data known | 8 | 100 | - | 284 | 96.60 | 100 | |
| Student | 0 | 0 | - | 93 | 31.63 | 32.75 | |
| Business man/woman | 3 | 37.50 | - | 37 | 12.59 | 13.03 | |
| Medical profession | 1 | 12.50 | - | 6 | 2.04 | 2.11 | |
| Gastronomy | 0 | 0 | - | 3 | 1.02 | 1.06 | |
| Other | 0 | 0 | - | 27 | 9.18 | 9.51 | |
| None | 4 | 50.00 | - | 118 | 40.13 | 41.55 | |
| Period of residency in Dar es Salaam | 0.92 | ||||||
| Data known | 8 | 100 | - | 285 | 96.94 | 100 | |
| 3–10 years | 1 | 12.50 | - | 48 | 16.33 | 16.84 | |
| 11–20 years | 4 | 50.00 | - | 113 | 38.44 | 39.65 | |
| 21–30 years | 0 | 0 | - | 73 | 24.83 | 25.61 | |
| 31–85 years | 3 | 37.50 | - | 51 | 17.35 | 17.89 | |
| Pork consumption | 0.72 | ||||||
| Data known | 8 | 100 | - | 292 | 99.32 | 100 | |
| Yes | 5 | 62.50 | - | 150 | 51.02 | 51.37 | |
| No | 3 | 37.50 | - | 142 | 48.30 | 48.63 | |
| Pork consumption by family | 0.26 | ||||||
| Data known | 7 | 87.50 | 100 | 292 | 99.32 | 100 | |
| Yes | 6 | 75.00 | 85.71 | 179 | 60.88 | 61.30 | |
| No | 1 | 12.50 | 14.29 | 113 | 38.44 | 38.70 | |
| Latrine usage | 0.55 | ||||||
| Data known | 8 | 100 | - | 236 | 80.27 | 100 | |
| Always | 7 | 87.50 | - | 214 | 72.79 | 90.68 | |
| Sometimes | 1 | 12.50 | - | 22 | 7.48 | 9.32 | |
| Intake of anthelmintic drug in the past twelve months | 0.45 | ||||||
| Data known | 8 | 100 | - | 224 | 76.19 | 100 | |
| Yes | 1 | 12.50 | - | 64 | 21.77 | 28.57 | |
| No | 7 | 87.50 | - | 160 | 54.42 | 71.43 | |
a Proportions among the total number of people with epilepsy, regardless of their data being known or not.
b Proportions among the total number of people with epilepsy, whose data are known.
c Fisher’s exact test was used if at least one cell of the contingency table was below 5.
Neurological and psychiatric characteristics of people with epilepsy seropositive and seronegative for T. solium cysticercosis and taeniasis.
| Variables | People with epilepsy | Post hoc | ||||||
|---|---|---|---|---|---|---|---|---|
| seropositive for | seronegative for | |||||||
| Number | Proportions | Proportions | Number | Proportions | Proportions | |||
| Total | 8 | 100 | - | 294 | 100 | - | ||
| Type of anti-epileptic drug (AED) | 1.00 | |||||||
| Data known | 8 | 100 | - | 260 | 88.44 | 100 | ||
| Carbamazepine | 4 | 50.00 | - | 122 | 41.50 | 46.92 | ||
| Phenobarbitone | 3 | 37.50 | - | 100 | 34.01 | 38.46 | ||
| Combination / other AED | 1 | 12.50 | - | 38 | 12.93 | 14.62 | ||
| Chronic progressive headaches | 0.70 | |||||||
| Data known | 8 | 100 | - | 232 | 78.91 | 100 | ||
| Yes | 5 | 62.50 | - | 162 | 55.10 | 69.83 | ||
| No | 3 | 37.50 | - | 70 | 23.81 | 30.17 | ||
| Family history of seizures | 0.43 | |||||||
| Data known | 7 | 100 | - | 289 | 98.30 | 100 | ||
| Yes | 1 | 14.29 | - | 100 | 34.01 | 34.60 | ||
| No | 6 | 85.71 | - | 189 | 64.29 | 65.40 | ||
| Age at first seizure | 0.03* | |||||||
| Data known | 8 | 100 | - | 291 | 98.98 | 100 | ||
| 5–10 years | 0 | 0 | - | 100 | 34.01 | 34.36 | 0.06 | |
| 11–20 years | 4 | 50.00 | - | 128 | 43.54 | 43.99 | 0.74 | |
| 21–30 years | 1 | 12.50 | - | 35 | 11.90 | 12.03 | 1.00 | |
| 31–85 years | 3 | 37.50 | - | 28 | 9.52 | 9.62 | 0.04* | |
| Frequency of seizures per month before treatment | 0.61 | |||||||
| Data known | 8 | 100 | - | 284 | 96.60 | 100 | ||
| 0.08–0.9 | 2 | 25.00 | - | 49 | 16.67 | 17.25 | ||
| 1.0–1.9 | 2 | 25.00 | - | 60 | 20.41 | 21.13 | ||
| 2.0–2.9 | 1 | 12.50 | - | 60 | 20.41 | 21.13 | ||
| 3.0–9.9 | 0 | 0 | - | 55 | 18.71 | 19.37 | ||
| 3 | 37.50 | - | 60 | 20.41 | 21.13 | |||
| Type of seizures | 0.04* | |||||||
| Gwa | 2 | 25.00 | - | 171 | 58.16 | - | 0.08 | |
| Goa | 1 | 12.50 | - | 44 | 14.97 | - | 1.00 | |
| Gua | 0 | 0 | - | 2 | 0.68 | - | 1.00 | |
| Gfs | 3 | 37.50 | - | 66 | 22.45 | - | 0.39 | |
| Gbd | 0 | 0 | - | 11 | 3.74 | - | 1.00 | |
| Sp | 2 | 25.00 | - | 0 | 0 | - | <0.01* | |
| Motor activity during seizures | 1.00 | |||||||
| Tonic | 0 | 0 | - | 28 | 9.52 | - | ||
| Clonic | 0 | 0 | - | 12 | 4.08 | - | ||
| Tonic / clonic | 7 | 87.50 | - | 208 | 70.75 | - | ||
| None | 1 | 12.50 | - | 46 | 15.65 | - | ||
| Aura present before seizures | 0.03* | |||||||
| Yes | 7 | 87.50 | - | 131 | 44.56 | - | ||
| No | 1 | 12.50 | - | 163 | 55.44 | - | ||
| Injuries during seizures | 0.55 | |||||||
| Data known | 8 | 100 | - | 293 | 99.66 | 100 | ||
| Bruise/hematoma | 2 | 25.00 | - | 37 | 12.59 | 12.63 | ||
| Burn injury | 0 | 0 | - | 11 | 3.74 | 3.75 | ||
| Other | 0 | 0 | - | 5 | 1.70 | 1.71 | ||
| None | 6 | 75.00 | - | 240 | 81.63 | 81.91 | ||
| Psychiatric illness | 1.00 | |||||||
| Data known | 7 | 87.5 | 100 | 293 | 99.66 | 100 | ||
| Yes | 4 | 50.0 | 57.14 | 159 | 54.08 | 54.27 | ||
| No | 3 | 37.5 | 42.86 | 134 | 45.58 | 45.73 | ||
Gwa: generalized seizures that started within a specific age range (seizures most likely due to idiopathic epilepsy); Goa: generalized seizures that started outside the age range of idiopathic epilepsy but without any obvious sign or history of an underlying cause; Gua: generalized seizures with unknown age of onset; Gfs: generalized seizures with obvious focal neurological signs; Gbd: generalized seizures with more widespread brain damage; Sp: simple partial seizures.
a Proportions among the total number of people with epilepsy, regardless of their data are known or not.
b Proportions among the total number of people with epilepsy, whose data are known.
c Fisher’s exact test was used if at least one cell of the contingency table was below 5.
Serological, neurological and radiological characteristics of people with epilepsy seropositive for T. solium cysticercosis and taeniasis.
| Variables | Patient number (P) | |||||||
|---|---|---|---|---|---|---|---|---|
| P1 | P2 | P3 | P4 | P5 | P6 | P7 | P8 | |
| Age (years) | 19 | 39 | 18 | 27 | 18 | 60 | 44 | 32 |
| Sex | female | male | female | male | female | female | male | male |
| Definitive NCC case | no | yes | yes | yes | no | yes | yes | yes |
| Epileptic seizures since (years) | 7 | 4 | 4 | 9 | 7 | 1 | 3 | 5 |
| Age when epileptic seizures started (years) | 13 | 35 | 14 | 18 | 11 | 59 | 41 | 27 |
| Chronic progressive headaches | yes | no | yes | no | yes | yes | yes | no |
| Psychiatric symptoms | yes | no | NK | no | yes | yes | yes | no |
| Laboratory findings (1st examination) | ||||||||
| CC-Ag | n | p | n | n | n | n | p | p |
| CC-Abs (LLGP) | p | p | p | p | Gp50 | p | p | p |
| CC-Abs (rT24H) | p | p | p | p | n | p | p | p |
| Taeniasis-Abs | n | p | n | n | n | n | n | p |
| Computed tomography findings (1st examination) | ||||||||
| Calcifications | no | yes | yes | yes | no | yes | yes | no |
| Viable cysts | no | yes | no | no | no | no | yes | no |
| Number of lesions | none | mult | mult | mult | none | mult | mult | none |
| Perifocal edema | no | yes | no | no | no | no | yes | no |
| Laboratory findings (2nd examination) | ||||||||
| CC-Ag | n | p | n | n | n | n | p | p |
| CC-Abs (LLGP) | Gp50 | (p) | p | p | p | Gp50 | p | n |
| CC-Abs (rT24H) | n | p | p | p | p | (p) | p | n |
| Taeniasis-Abs | n | n | (p) | n | (p) | n | p | n |
| Copro-Ag | n | n | n | n | n | n | n | n |
| Computed tomography findings (2nd examination) | ||||||||
| Calcifications | no | yes | yes | yes | no | yes | yes | yes |
| Viable cysts | no | no | no | no | no | no | yes | yes |
CC: cysticercosis; Ag: antigen; Abs: antibodies; NCC: neurocysticercosis; NK: not known; LLGP: lentil lectin purified glycoprotein enzyme-linked immunoelectrotransfer blot; rT24H: rT24H-immunoblot; p: positive; n: negative; (p): weak positive; Gp50: only the glycoprotein 50-band was detected on the strip; mult: multiple.
a According to the revised diagnostic criteria proposed by Del Brutto [25] and based on both examinations.
b Follow-up after eight to ten months.
c Copro-Ag testing by an enzyme-linked immunosorbent assay could only be performed with the samples of the 2nd examination due to study limitations.
d No information about number and lesions and perifocal edemas were available from the second CT scans, except P8 who had multiple calcifications and viable cysts.